BioGend Therapeutics Market Cap

BioGend Therapeutics has a market cap or net worth of 4.78 billion as of December 5, 2025. Its market cap has increased by 2.76% in one year.

Market Cap

4.78B

Enterprise Value

4.27B

Revenue

212.43M

Ranking

n/a

PE Ratio

n/a

Stock Price

38.40

Market Cap Chart

Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 4.78B, an increase of 75.94%. That is a compound annual growth rate of 9.12%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	4.78B	14.21%
Dec 31, 2024	4.18B	-11.18%
Dec 29, 2023	4.71B	109.50%
Dec 30, 2022	2.25B	-18.50%
Dec 30, 2021	2.76B	-22.86%
Dec 31, 2020	3.57B	46.27%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	283.81B
PharmaEssentia	189.73B
Lotus Pharmaceutical	78.24B
Bora Pharmaceuticals Co., LTD.	65.19B
Oneness Biotech	33.97B
Lin BioScience	33.46B
Lumosa Therapeutics	32.34B
Center Laboratories	28.11B

Market Cap Rankings